Neurology News
Expand your brainpower with neurology news focused on the diagnosis and treatment of nervous system disorders. Find the latest research in brain development and advancements in the treatment of tumors, seizure and spinal cord disorders, muscular dystrophy, multiple sclerosis, Alzheimer’s and infections of the nervous system, such as meningitis.
Augie’s Quest to Cure ALS Completes $5.8 Million Commitment to Fund ALS TDI’s Translational Research Center
The ALS Therapy Development Institute (ALS TDI) is proud to announce that Augie’s Quest to Cure ALS has fulfilled its $5.8 million commitment, pledged in 2021, to advance ALS research. This transformative funding has directly supported the Augie’s Quest Translational Research Center... - December 13, 2024 - ALS Therapy Development Institute
NeuroDex Awarded Target ALS Biomarker Consortia Grant to Drive Advancements in ALS Research
NeuroDex Awarded Target ALS Biomarker Consortia Grant to Drive Advancements in ALS Research - November 09, 2024 - NeuroDex
Synaps Dx Launches Digital Cognitive Screening and Alzheimer’s Testing with BrainCheck and Clarity Health Clinics
Synaps Dx, BrainCheck, and Clarity Health introduce an innovative online Alzheimer's and cognitive health screening tool, accessible from home. Launching in Texas, with nationwide expansion planned, this telehealth solution provides families with a convenient, reliable path to early detection during National Alzheimer’s Disease Awareness Month, reducing the need for in-office visits and empowering proactive cognitive care. - November 04, 2024 - SynapsDx
Rare Disease Foundation on the Road to Gene Therapy Brings Families to Fort Lauderdale from Around the World, November 15-17
The FOXG1 Research Foundation, the parent-led organization that is radically transforming the rare disease drug development landscape, is hosting an international conference in Fort Lauderdale from November 15-17, bringing families from across the globe together to learn about gene therapy advancements for FOXG1 syndrome. A highlight includes a presentation by 20-year-old Abraham Weitzman, who, though non-speaking, shares his lived experience using an innovative communication device. - November 04, 2024 - FOXG1 Research Foundation
Championing the Theme, Equity Works, Clubhouse International Partners with World Federation for Mental Health and 25 Clubhouses for World Mental Health Day
This World Mental Health Day, Clubhouse International is joined by 25 participating member Clubhouses and the World Federation for Mental Health for a campaign that champions the transformative power of equity, a critical aspect of the Clubhouse approach to recovery, which helps empower individuals and transform communities. - October 10, 2024 - Clubhouse International
October is Havana Syndrome Awareness Month
October is Havana Syndrome Awareness Month. The purpose is to raise awareness about Havana Syndrome injuries caused by directed energy. - October 05, 2024 - Havana Syndrome, Inc.
Adapy, Inc. Awarded Phase 1 SBIR Grant by NIDILRR to Advance Mobility Solutions
Adapy, Inc. has received a Phase 1 SBIR grant from NIDILRR to advance its innovative harness technology interfacing with its Smart Mobility System. This grant supports Adapy’s mission to improve mobility for individuals with disabilities, enhancing safety and independence. - October 02, 2024 - Adapy, Inc.
Dr. Pratistha Sachan, Renowned Vertigo Specialist, Delivers Pioneering Case Presentation at NESCON 2024
Dr. Pratistha Sachan, the foremost Vertigo Specialist and first Certified Vestibular Specialist in Lucknow, recently delivered a pioneering case presentation at NESCON 2024. Her presentation focused on the latest advancements in vertigo diagnosis and treatment, showcasing her innovative approaches to managing complex vestibular disorders. Dr. Sachan's participation in this prestigious event highlights her commitment to excellence in patient care. - September 08, 2024 - Dr Pratistha Sachan
Huntington Study Group and HD Genetics Collaborate to Better Serve HD Gene Positive Patients
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce a strategic partnership with HD Genetics to assist patients who have tested positive for Huntington’s disease (HD) learn about and enroll in research studies. There remains a... - September 05, 2024 - Huntington Study Group
ALS Therapy Development Institute Commemorates 25th Anniversary at the Leadership Weekend in October
Taking place from October 3-5, 2024, in the Boston area, ALS TDI’s Leadership Weekend features a series of community-focused events, including an Open House at ALS TDI’s cutting-edge research lab, the ALS TDI Research Summit, and the White Coat Affair gala. - September 03, 2024 - ALS Therapy Development Institute
Huntington Study Group Announces New CEO
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce that Daniel Claassen, MD, MS, an internationally recognized Huntington’s Disease neurologist and researcher has accepted the role as the organization’s Chief Executive... - August 20, 2024 - Huntington Study Group
Blink DC Launches Its Second Generation TwitchView® System, A Quantitative Neuromuscular Monitor
Blink Device Company announces the launch of the TwitchView®2 System, the second generation of its electromyographic (EMG) quantitative neuromuscular monitoring system. A complete redesign based on experience in over 1,000,000 clinical cases around the world. Designed to withstand OR abuse and to perform reliably in even the most difficult-to-monitor patients. - August 14, 2024 - Blink Device Company
Silver Scott Mines, Inc. Signs Letter of Intent to Acquire Innovative, Patented Non-Invasive Brain Treatment Technology
Silver Scott Mines will be acquiring the assets of AddBrain, Inc.’s technology. It has been used to treat Huntington’s Disease, Parkinson’s and Suicidal Depression with excellent results. There are ongoing clinical trials in Canada. - August 02, 2024 - Silver Scott Mines, Inc.
SYNAPS Dx Welcomes Renowned Alzheimer’s Researcher, Dr. Donna Wilcock, to Its Scientific Advisory Board
SYNAPS Dx welcomes Dr. Donna M. Wilcock, a leading Alzheimer's researcher, to its Scientific Advisory Board. Dr. Wilcock's expertise in neuroinflammation and vascular cognitive impairment will support the advancement of the DISCERN™ diagnostic test for Alzheimer's disease. This addition reinforces SYNAPS Dx’s commitment to pioneering accurate, minimally invasive diagnostics for Alzheimer's. For more info, visit SYNAPS Dx's website. - July 15, 2024 - SynapsDx
SYNAPS Dx Announces Expansion to New, State-of-the-Art Facility
SYNAPS Dx has moved to a new, state-of-the-art facility in Rockville, MD, to meet growing demand and enhance patient care. The larger space and advanced infrastructure will support more diagnostic samples and ensure timely, accurate Alzheimer's and dementia diagnoses. Fully qualified for high-complexity clinical lab testing, the facility boosts diagnostic capabilities. The expansion will also advance the DISCERN™ test, a minimally invasive tool distinguishing Alzheimer's from other dementias. - June 26, 2024 - SynapsDx
Groundbreaking Study Shows Promise in AAV9 Gene Therapy for FOXG1 Syndrome; Rescue of Brain Structure Abnormalities and Deficits.
New publication shows groundbreaking result in FOXG1 AAV9 gene therapy studies, rescuing structural brain abnormalities caused by the pediatric rare disease, FOXG1 syndrome. This paper summarizing work done by the FOXG1 Research Center, led by Dr. Soo-Kyung Lee, Dr. Jae W. Lee and Dr. Kathrin Meyer (responsible for the SMA gene therapy), shows remarkable rescue of brain abnormalities using AAV9 gene therapy. - June 10, 2024 - FOXG1 Research Foundation
JSE Releases New Streamline EHR to Increase Productivity
In an era where technology continually reshapes industries, Juggernaut Systems Express stands out as a beacon of innovation. With a solid foundation of twelve years in the market, the company has leveraged its extensive experience to develop MindTherapy.works, a cutting-edge application designed to... - June 03, 2024 - Juggernaut Systems Express
Vesalio Appoints CFO and Announces Company Headquarters in Dallas, Texas
Vesalio hires J.D. McCulloch as Chief Financial Officer and announces the establishment of the company’s headquarters in Dallas, Texas. - May 21, 2024 - Vesalio
Clubhouse International and Fountain House Launch 2024 Clubhouse Week of Action
Clubhouse International and Fountain House today announced their 2024 Clubhouse Week of Action, a dedicated time when Clubhouses across the country will be engaging their representatives, local businesses, the media, and others in the community on the holistic Clubhouse Model of mental illness recovery. - May 21, 2024 - Clubhouse International
Huntington Study Group Launches Project AWARE 2.0 Observational Study
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce the launch of Project AWARE 2.0, an observational study developed in collaboration with Roche Products Limited and Genentech to understand and improve Awareness, Willingness, and... - April 10, 2024 - Huntington Study Group
Understanding Parkinson's Disease at Right at Home's Community Speaker Session
Right at Home is honored to announce the next free community speaker session, which aims to educate and empower the community about Parkinson's Disease. - April 01, 2024 - Right at Home - In-Home Care & Assistance
ALS TDI Launches ALS Trial Navigator: A Revolutionary Platform to Simplify Access to Clinical Trials
The ALS Therapy Development Insitute (ALS TDI) has announced the beta launch of the ALS Trial Navigator. This innovative set of tools is designed to guide people with ALS and caregivers through the process of finding and understanding ALS clinical trials – with the ultimate goal of personalizing the search process and helping users make informed decisions about participation in trials. - February 29, 2024 - ALS Therapy Development Institute
Black Hills Surgical Hospital Ranked #1 Hospital in the Nation for 2nd Consecutive Year for Major Orthopedic Surgery in Medical Excellence and Patient Safety Rankings
For the second year in a row, Black Hills Surgical Hospital (BHSH) has been ranked as the #1 Hospital in the Nation for Major Orthopedic Surgery for Medical Excellence by CareChex®. BHSH has also been ranked as the #1 Hospital in the Nation for Major Orthopedic Surgery for Patient Safety – achieving the nation’s top ranking in both categories. - February 19, 2024 - Black Hills Surgical Hospital
Huntington Study Group Announces 2024 Annual Meeting
The Huntington Study Group® (HSG), together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease (HD), is pleased to announce that its annual meeting for 2024 is slated to take place from November 6-9 at the... - January 22, 2024 - Huntington Study Group
TrialX Partners with The Michael J. Fox Foundation to Power Its Parkinson’s Clinical Trial Finder
To increase accessibility of information for individuals and families affected by Parkinson’s disease. - January 08, 2024 - TrialX
Clubhouse International Celebrates 30 Years of Change
Clubhouse International, the only global non-profit, non-governmental organization that helps communities around the world create sustainable solutions for mental illness, celebrates the 30th Anniversary of its founding in 2024. Joel D. Corcoran, CEO and Executive Director of Clubhouse... - January 04, 2024 - Clubhouse International
Dementia Society of America Named Finalist in Anthem Awards for Its National PSA Campaign
Dementia Society of America® (DSA) announced that it has been selected as a Finalist in the 3rd Annual Anthem Awards for its national Public Service Announcement (PSA) campaign. This campaign has been instrumental in driving awareness and education about Dementia and promoting brain health... - January 01, 2024 - Dementia Society of America
Christopher Ng, MD, Joins New York Health as Chief Medical Officer - Executive Director
New York Health (NY Health) is proud to announce the appointment of Christopher Ng, MD, as its new Chief Medical Officer (CMO) and Executive Director. As CMO, Dr. Ng will lead and oversee all medical aspects of the practice, ensuring the delivery of outstanding medical care while complying with... - December 19, 2023 - New York Health
Huntington Study Group and Roche Collaborate on GENERATION HD2 Study
The Huntington Study Group together with its wholly-owned clinical research organization, HSG Clinical Research, Inc. (HSGCR), is pleased to announce a collaboration with Roche-Genentech to optimize our collective experiences in Huntington’s disease (HD) clinical research. Together we are... - December 13, 2023 - Huntington Study Group
Expert Panel Provides Updated Data for Epilepsy and Pregnancy
The Epilepsy & Pregnancy Medical Consortium, an expert panel of leading epileptologists and OB-GYN researchers/practitioners, announced updated best practice recommendations for people with epilepsy who are considering pregnancy, are pregnant, or are postpartum. These new best practices are... - November 16, 2023 - Epilepsy & Pregnancy Medical Consortium
Indiana Parkinson Foundation Announces Pickleball 4 Parkinson’s Event
The Indiana Parkinson Foundation has officially announced its inaugural 2023 Pickleball 4 Parkinson’s Event. This single-day event will have beginner, advanced and intermediate rounds as well as courts reserved to teach players with Parkinson’s how they can adapt and play their best... - November 01, 2023 - Indiana Parkinson Foundation
Palliative Medicine Physician Joannis Baez Gonzalez, MD, Joins New York Cancer & Blood Specialists
New York Cancer & Blood Specialists (NYCBS), one of the nation's leading oncology practices, is proud to announce the addition of board-certified Palliative Medicine Physician Dr. Baez Gonzalez. Dr. Baez Gonzalez will practice at 6118 190th Street, Suite 217, Fresh Meadows, NY... - November 01, 2023 - New York Cancer & Blood Specialists
Huntington Study Group® Observational Pilot Study Shows HSG’s myHDstory® Platform Reaches the Unreachable
The Huntington Study Group® (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc. (HSGCR), a world leader in conducting clinical trials for Huntington’s disease (HD), today announces that the pilot observational study on their innovative online direct-to-patient... - October 16, 2023 - Huntington Study Group
Clubhouse International Partners with World Federation for Mental Health in Recognition of World Mental Health Day and the Power of Community
Clubhouse International, a global mental health organization, presents Community WORKS, a World Mental Health Day 2023 campaign that highlights the positive impact of community for people living with mental illness. Community, which is the core of the Clubhouse Model of psychosocial rehabilitation, helps end social isolation and transforms lives. - October 10, 2023 - Clubhouse International
Small Audiology Practice in Northeast Ohio Selected as One of Only 44 Practices in US to Fit Groundbreaking Tinnitus Treatment Device
The Lenire tinnitus treatment device was approved by the FDA in April 2023. It was initially fit by only 14 practices nationwide but the company, Neuromod (based in Ireland), added 30 additional audiology practices in Phase 2 of its release for a total of 44 practices. Sounds of Life Hearing Center was selected to be in this select group of practices and is now certified to prescribe and fit this device which uses tongue-tip and sound stimulation to change the way the brain perceives tinnitus. - October 07, 2023 - Sounds of Life Hearing Center, LLC
Max Planck Florida Researcher Receives Prestigious NIH New Innovator Award
Research into the neural mechanisms underlying addiction and eating disorders has earned Max Planck Florida Institute for Neuroscience researcher Dr. Sarah Stern an NIH Director’s New Innovator Award. This award will provide Dr. Stern and MPFI with $2.85 million in research funding support over five years, and is part of the NIH’s High-Risk-High Reward Research Program of the NIH Common Fund. - October 02, 2023 - Max Planck Florida Institute for Neuroscience
Alevea Mental Health Advocates for Psychedelic Therapy, Citing MAPS' Latest Research and Its Own Success with Ketamine Treatment
Alevea Mental Health fully endorses psychedelic therapy as an effective mental health treatment, following the recent publication of MAPS' Phase 3 study on MDMA-assisted therapy for PTSD. Alevea has already reported significant success in alleviating symptoms of anxiety, depression, and PTSD through its own Ketamine treatment programs. CEO Topher Bradshaw expressed astonishment at the remarkable patient improvements, particularly when other treatments had failed. - September 20, 2023 - Alevea Mental Health
National Brain Tumor Society to Launch Campaigns Elevating the Necessity of Clinical Trials and Biomarker Testing Access, Guiding More Informed Treatment Decisions
Joint initiatives aim to help patients and families navigate the era of precision medicine in cancer care. - September 13, 2023 - National Brain Tumor Society
MPFI’s Wang Lab Awarded $1M Grant to Study Mechanism Behind Memory Decline in Alzheimer’s
Memory loss is one of the most devastating effects of Alzheimer's disease, yet the mechanisms behind it remain a mystery. MPFI is working to change that through a new $1,038,819 research award from the National Institute on Aging of the NIH. - August 23, 2023 - Max Planck Florida Institute for Neuroscience
Huntington Study Group Welcomes FDA Approval of New Drug for Chorea in Huntington’s Disease
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in clinical trials for Huntington’s disease (HD), today shares that the Phase 3 pivotal KINECT®-HD study conducted by HSG in collaboration with Neurocrine Biosciences,... - August 18, 2023 - Huntington Study Group
Huntington Study Group Announces Positive Topline Results for Virtual Unified Huntington’s Disease Rating Scale® (vUHDRS®) Study
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease (HD), today announces positive topline results from its Virtual Unified Huntington’s Disease Rating Scale®... - August 14, 2023 - Huntington Study Group
Neurobit Launches Neurobit HUB: A Comprehensive Tool for Streamlining Sleep and Population Health Research
Neurobit announces the launch of Neurobit HUB, a groundbreaking AI-driven tool for sleep and population health research. Integrating 40 sleep biomarkers, 20 health AI modules, and clinically validated devices, it's designed to streamline clinical trials, foster collaboration, and accelerate discoveries. A revolutionary step in sleep science. Learn more at https://www.neurobit.com/research/hub - August 14, 2023 - neurobit
The FOXG1 Research Foundation Appoints Dr. Soo-Kyung Lee as Chief Scientific Officer to Lead Therapeutics for FOXG1 Syndrome, an Autism-related Rare Disease
The FOXG1 Research Foundation (FRF), a parent-led rare disease patient organization focused on driving therapeutics for FOXG1 syndrome, an Autism-related neurological condition, announced today the appointment of Dr. Soo-Kyung Lee as the new Chief Scientific Officer of the FOXG1 Research Foundation (FRF). Dr. Lee’s dedication to curing FOXG1 syndrome is deeply personal as a mother to Yuna, diagnosed with FOXG1 syndrome in 2009. - August 12, 2023 - FOXG1 Research Foundation
Swedish Medical Center is Nationally Recognized for Its Commitment to Providing High-Quality Stroke Care
The American Heart Association presents Get With The Guidelines - Stroke Gold Plus award for proven dedication to ensuring all stroke patients have access to best practices and life-saving care. - July 27, 2023 - HCA HealthONE Swedish
NDR Medical Technology’s ANT-X Granted FDA Clearance, Paving the Way for Image-Guided Surgeries
ANT-X is an interventional robot that leverages C-arm fluoroscopy to help clinicians achieve swift and accurate percutaneous needle placement. NDR Medical Technology, an AI-empowered interventional robotics company, today announced that the ANT-X has been granted FDA 510(k) clearance by the U.S. - July 17, 2023 - NDR Medical Technology
Neurology 2024 Gathering in Bangkok, Thailand
The Neuro and Brain Disorders International Summit will go hybrid next May 2024. - June 29, 2023 - Scientex Conferences
Retirement Reception for Dr. Deborah Flanagan, Introducing Dr. Caleb Saint Jean
Dr. Caleb Saint Jean will be hosting a Retirement Reception for Dr. Deborah Flanagan at Eyes on Central, 4940 Central Avenue, on Tuesday, June 27 from 4 p.m. to 8 p.m. - June 23, 2023 - Eyes on Central
Kristen M. Toepfer Awarded Lifetime Achievement Award by P.O.W.E.R. - Professional Organization of Women of Excellence Recognized
Kristen M. Toepfer of Hackettstown, New Jersey has been honored with a Lifetime Achievement Award by P.O.W.E.R. (Professional Organization of Women of Excellence Recognized) for her outstanding contributions and great success in the fields of nonprofit and volunteering. The Lifetime Achievement... - June 07, 2023 - P.O.W.E.R. Professional Organization of Women of Excellence Recognized
Clubhouse International Hosts Global Initiative to Raise Awareness and Funding for the Clubhouse Approach to Recovery
Clubhouse International is proud to power Clubhouse Giving Day™. Now in its third year, the initiative offers an excellent opportunity for the global Clubhouse network to come together to raise awareness about mental illness and to raise funds that will grow and strengthen the Clubhouse approach to recovery around the world. - June 01, 2023 - Clubhouse International
Neurocrine Biosciences Announces Publication of Full KINECT™-HD Phase 3 Study Results of Valbenazine
Neurocrine Biosciences Announces Publication of Full KINECT™-HD Phase 3 Study Results of Valbenazine for the Treatment of Chorea Associated with Huntington’s Disease in The Lancet Neurology. - Statistically Significant Improvement in Chorea Associated with Huntington’s Disease... - May 19, 2023 - Huntington Study Group